Mark K Meiselbach - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mark K Meiselbach

Showing results (31-40 of 50) with videos related to

Pageof 5

Sort By:

Rheumatology and Therapy|January 7, 2019

Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart ReviewPrashanth Sunkureddi, Dominick Latremouille-Viau, Mark K Meiselbach, et al.

JAMA Internal Medicine|April 26, 2021

Frequency and Costs of Out-of-Network Bills for Outpatient Laboratory Services Among Privately Insured PatientsAditi P Sen, Mark K Meiselbach, Yang Wang, et al.

Drugs - Real World Outcomes|January 9, 2019

Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart ReviewReeti Joshi, Dominick Latremouille-Viau, Mark K Meiselbach, et al.

Open Forum Infectious Diseases|June 27, 2018

Risk Factors for Self-Reported Cholera Within HIV-Affected Households in Rural HaitiAaron Richterman, Hoi Ching Cheung, Mark K Meiselbach, et al.

Journal of Addiction Medicine|June 4, 2024

Racial and Ethnic Disparities in Geographic Availability of BuprenorphineColeman Drake, Dylan Nagy, Mark K Meiselbach, et al.

Medical Care Research and Review : MCRR|April 21, 2023

State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed CareMark K Meiselbach, Coleman Drake, Jane M Zhu, et al.

The American Journal of Managed Care|October 17, 2022

The impact of HDHPs on service use and spending for substance use disordersMatthew D Eisenberg, Alene Kennedy-Hendricks, Cameron Schilling, et al.

Journal of General Internal Medicine|August 18, 2021

Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use DisorderAlene Kennedy-Hendricks, Cameron J Schilling, Alisa B Busch, et al.

BMJ Open|March 24, 2018

Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer's disease diagnosis: a pilot study in EnglandGrazia Dell'Agnello, Urvi Desai, Noam Y Kirson, et al.

Psychiatric Services (Washington, D.C.)|September 30, 2021

Effects of High-Deductible Health Plans on Enrollees With Mental Health Conditions With and Without Substance Use DisordersCameron J Schilling, Matthew D Eisenberg, Alene Kennedy-Hendricks, et al.

Pageof 5

Search research articles

Showing results (31-40 of 50) with videos related to

Sort By:

Pageof 5

Rheumatology and Therapy|January 7, 2019

JAMA Internal Medicine|April 26, 2021

Frequency and Costs of Out-of-Network Bills for Outpatient Laboratory Services Among Privately Insured PatientsAditi P Sen, Mark K Meiselbach, Yang Wang, et al.

Drugs - Real World Outcomes|January 9, 2019

Open Forum Infectious Diseases|June 27, 2018

Risk Factors for Self-Reported Cholera Within HIV-Affected Households in Rural HaitiAaron Richterman, Hoi Ching Cheung, Mark K Meiselbach, et al.

Journal of Addiction Medicine|June 4, 2024

Racial and Ethnic Disparities in Geographic Availability of BuprenorphineColeman Drake, Dylan Nagy, Mark K Meiselbach, et al.

Medical Care Research and Review : MCRR|April 21, 2023

State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed CareMark K Meiselbach, Coleman Drake, Jane M Zhu, et al.

The American Journal of Managed Care|October 17, 2022

The impact of HDHPs on service use and spending for substance use disordersMatthew D Eisenberg, Alene Kennedy-Hendricks, Cameron Schilling, et al.

Journal of General Internal Medicine|August 18, 2021

Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use DisorderAlene Kennedy-Hendricks, Cameron J Schilling, Alisa B Busch, et al.

BMJ Open|March 24, 2018

Psychiatric Services (Washington, D.C.)|September 30, 2021

Effects of High-Deductible Health Plans on Enrollees With Mental Health Conditions With and Without Substance Use DisordersCameron J Schilling, Matthew D Eisenberg, Alene Kennedy-Hendricks, et al.

Pageof 5